Wasn't able to get to a "Top Three" yesterday, as I was attending a (VERY interesting) real-time communications conference in NYC. Blog post coming on that. Meanwhile... Pfizer, Pfizer, Pfizer. 800 …
Pharma News this week
Some surprises in the new diabetes guidelines issue by the American Diabetes Association and European Association for the Study of Diabetes...more Speaking of diabetes - we're paying a lot more over …
Pharma News 10_03
Is Eli Lilly the "mystery suitor" for ImClone? - Eli Lilly & Co. is in advanced talks to buy cancer-drug developer ImClone Systems for $70 a share, or $6.1 billion, The Wall Street Journal …
Pharma News 7_5
Prasugrel review extended - Daiichi Sankyo Company, Limited, and Eli Lilly and Company said that the U.S. Food and Drug Administration (FDA) has extended the review period for the prasugrel new drug …
Pharma News 6_23
Cymbalta approved for Fibromyalgia - The U.S. Food and Drug Administration (FDA) has approved Cymbalta® (duloxetine HCl) for the management of fibromyalgia, a chronic widespread pain disorder, Eli …